Leslie Ballard, MD
Obstetrics & Gynecology · Skagway, AKNPI 1922069335
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Sunovion Pharmaceuticals Inc. accounts for 87.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $296 and has fallen 94.4% since, to $17 in 2024.
Across 64 payments — averaging $10.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$615
- Tactile Systems Technology Inc$40
- Sun Pharmaceutical Industries Inc.$30
- Indivior Inc.$17
What the payments were for
- Food & beverage$701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 59 | $615 |
| Tactile Systems Technology Inc | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Indivior Inc. | 1 | $17 |
How this compares
$701 in reported general payments places this provider in the 60th percentile of 97 obstetrics & gynecology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 20 | $22,329 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $18,360 |
| TradjentaLinagliptin | 15 | $8,849 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $510 |
| Rosuvastatin Calcium | 26 | $255 |
| Metoprolol Succinate | 15 | $195 |
| Amlodipine Besylate | 34 | $165 |
| Losartan Potassium | 26 | $142 |
| Lisinopril | 21 | $111 |
| Trazodone Hcl | 15 | $84 |
| Atorvastatin Calcium | 13 | $72 |
| Levofloxacin | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Skagway
- Christy SouthPalmer$19K
- Nicholas NewburyJuneau$9K
- Melissa TondreAnchorage$9K
- Kathryn OstromHomer$9K
- Patricia CapoAnchorage$9K
- Shiloh SmallAnchorage$9K
- John HoughtonPalmer$7K
- Allison van HaastertAnchorage$6K
- Natalia SaprykinaAnchorage$6K
- Jessica GoldbergerAnchorage$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.